Africa Daily Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa Daily Journal.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on February 3, 2026

Feb. 3, 2026

South Africans Selling Gold and Krugerrands at Record Highs

EIN Presswire

Feb. 3, 2026

Deborah Ann Mack Fashions Celebrates Valentine’s Season With Custom Bridal and Heirloom Redesign Services

EIN Presswire

Feb. 3, 2026

StrongMinds Partners With Zambia Correctional Service To Treat Depression Among Inmates and Officers

EIN Presswire

Feb. 3, 2026

New E-book 'Command the Room Without Performance'

EIN Presswire

Feb. 3, 2026

Telix Full Year Results 2025 Investor Webcast Notification

GlobeNewswire

Feb. 3, 2026

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Feb. 3, 2026

Prelude Therapeutics Receives FDA Clearance of Investigational New Drug Application (IND) for PRT12396, a Mutant-selective JAK2V617F Inhibitor

GlobeNewswire

Feb. 3, 2026

Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ as Company Prepares for SOTERIA Trial Launch

GlobeNewswire

Feb. 3, 2026

Ardelyx Receives New Patent for Tenapanor

GlobeNewswire

Feb. 3, 2026

Beghou Names Meredith Ressi as President and Chief Growth Officer

GlobeNewswire

Feb. 3, 2026

Kyverna Therapeutics Appoints Mayo Pujols as Chief Technology Officer

GlobeNewswire

Feb. 3, 2026

Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire

Feb. 3, 2026

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Feb. 3, 2026

Excellent Achievements for Clearmind’s Proprietary MEAI that was Included in U.S. Congress’ Emerging Therapies Bill to Expand Veteran Access to Innovative Treatments

GlobeNewswire

Feb. 3, 2026

Highland Copper to Present at Upcoming Events

GlobeNewswire

Feb. 3, 2026

HPQ Silicon Increases Equity Stake in Novacium SAS, Strengthening Global Exposure and Short and Medium-Term Value Creation

GlobeNewswire

Feb. 3, 2026

HPQ Silicium augmente sa participation dans Novacium SAS, renforçant son exposition mondiale et la création de valeur à court et moyen terme

GlobeNewswire

Feb. 3, 2026

Invivyd Aligns with the U.S. FDA on LIBERTY, a Phase 3 Trial to Evaluate the Safety of VYD2311 Antibody Versus mRNA COVID Vaccine, and to Characterize the Safety and Immunology of Antibody and Vaccine Co-Administration

GlobeNewswire

Feb. 3, 2026

Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit

GlobeNewswire

Feb. 3, 2026

Relay Therapeutics Announces Zovegalisib Granted Breakthrough Therapy Designation by U.S. FDA for PIK3CA-mutant, HR+/HER2- Advanced Breast Cancer

GlobeNewswire